BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26285018)

  • 1. Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.
    Gehrau RC; Mas VR; Dumur CI; Suh JL; Sharma AK; Cathro HP; Maluf DG
    Transplantation; 2015 Dec; 99(12):2523-33. PubMed ID: 26285018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis.
    Croome KP; Lee DD; Croome S; Chadha R; Livingston D; Abader P; Keaveny AP; Taner CB
    Am J Transplant; 2019 Sep; 19(9):2550-2559. PubMed ID: 30821923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody.
    Xiao Z; Banan B; Xu M; Jia J; Manning PT; Hiebsch RR; Gunasekaran M; Upadhya GA; Frazier WA; Mohanakumar T; Lin Y; Chapman WC
    Transplantation; 2016 Jul; 100(7):1480-9. PubMed ID: 27331362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postreperfusion hyperkalemia in liver transplantation using donation after cardiac death grafts with pathological changes.
    Zhang WJ; Xia WL; Pan HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):487-492. PubMed ID: 27733317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response.
    Li CX; Ng KT; Shao Y; Liu XB; Ling CC; Ma YY; Geng W; Qi X; Cheng Q; Chung SK; Lo CM; Man K
    Ann Surg; 2014 Aug; 260(2):317-28. PubMed ID: 24699020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
    Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression.
    Man K; Fan ST; Lo CM; Liu CL; Fung PC; Liang TB; Lee TK; Tsui SH; Ng IO; Zhang ZW; Wong J
    Ann Surg; 2003 Feb; 237(2):256-64. PubMed ID: 12560784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Ischemic Preconditioning a Useful Therapeutic Strategy in Liver Transplantation? Results from the First Pilot Study in Mexico.
    Zapata-Chavira HA; Cordero-Pérez P; Casillas-Ramírez A; Escobedo-Villarreal MM; Pérez-Rodríguez E; Torres-González L; Camara-Lemarroy C; Hernández-Guedea MA; Caballero-Mendoza E; Muñoz-Espinosa LE
    Arch Med Res; 2015 May; 46(4):296-302. PubMed ID: 26074359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver steatosis in pre-transplant liver biopsies can be quantified rapidly and accurately by nuclear magnetic resonance analysis.
    Bertram S; Myland C; Swoboda S; Gallinat A; Minor T; Lehmann N; Thie M; Kälsch J; Pott L; Canbay A; Bajanowski T; Reis H; Paul A; Baba HA
    Virchows Arch; 2017 Feb; 470(2):197-204. PubMed ID: 27915440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatotic Livers Are More Susceptible to Ischemia Reperfusion Damage after Transplantation and Show Increased γδ T Cell Infiltration.
    Eggenhofer E; Groell A; Junger H; Kasi A; Kroemer A; Geissler EK; Schlitt HJ; Scherer MN
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm.
    Chavin KD; Taber DJ; Norcross M; Pilch NA; Crego H; McGillicuddy JW; Bratton CF; Lin A; Baliga PK
    Clin Transplant; 2013; 27(5):732-41. PubMed ID: 23991646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.
    Selzner N; Selzner M; Jochum W; Amann-Vesti B; Graf R; Clavien PA
    J Hepatol; 2006 Apr; 44(4):694-701. PubMed ID: 16229921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.
    Liss KHH; McCommis KS; Chambers KT; Pietka TA; Schweitzer GG; Park SL; Nalbantoglu I; Weinheimer CJ; Hall AM; Finck BN
    Liver Transpl; 2018 Jul; 24(7):908-921. PubMed ID: 29729104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
    Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
    Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of ischemia/reperfusion injury in time-zero biopsies predicts liver allograft outcomes.
    Ali JM; Davies SE; Brais RJ; Randle LV; Klinck JR; Allison ME; Chen Y; Pasea L; Harper SF; Pettigrew GJ
    Liver Transpl; 2015 Apr; 21(4):487-99. PubMed ID: 25545865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic expression profile of human liver grafts in ischemia-reperfusion injury: comparison of familial amyloidotic polyneuropathy and deceased-donor liver grafts.
    Paulino J; Vigia E; Marcelino P; Abade O; Sobral J; Ligeiro D; Carvalho A; Alves M; Papoila AL; Trindade H; Barroso E
    Transplant Proc; 2014; 46(6):1678-84. PubMed ID: 25131011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.